AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
DETECTION OF GENE DELETION AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN 103 GLIOMAS/
Authors: PERRY A ANDERL K BORELL TJ KIMMEL DW WANG CH OFALLON JR FEUERSTEIN BG SCHEITHAUER BW JENKINS RB
Citation: A. Perry et al., DETECTION OF GENE DELETION AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN 103 GLIOMAS/, Modern pathology, 11(1), 1998, pp. 161-161
EFFECTS OF RADIATION AND CHEMOTHERAPY ON COGNITIVE FUNCTION IN PATIENTS WITH HIGH-GRADE GLIOMA
Authors: TAYLOR BV BUCKNER JC CASCINO TL OFALLON JR SCHAEFER PL DINAPOLI RP SCHOMBERG P
Citation: Bv. Taylor et al., EFFECTS OF RADIATION AND CHEMOTHERAPY ON COGNITIVE FUNCTION IN PATIENTS WITH HIGH-GRADE GLIOMA, Journal of clinical oncology, 16(6), 1998, pp. 2195-2201
RANDOMIZED COMPARISON OF 4 TOOLS MEASURING OVERALL QUALITY-OF-LIFE INPATIENTS WITH ADVANCED CANCER
Authors: SLOAN JA LOPRINZI CL KUROSS SA MISER AW OFALLON JR MAHONEY MR HELD IM BRETSCHER ME VAUGHT NL
Citation: Ja. Sloan et al., RANDOMIZED COMPARISON OF 4 TOOLS MEASURING OVERALL QUALITY-OF-LIFE INPATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3662-3673
PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2A AND EFLORNITHINE INPATIENTS WITH RECURRENT GLIOMA
Authors: BUCKNER JC BURCH PA CASCINO TL OFALLON JR SCHEITHAUER BW
Citation: Jc. Buckner et al., PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2A AND EFLORNITHINE INPATIENTS WITH RECURRENT GLIOMA, Journal of neuro-oncology, 36(1), 1998, pp. 65-70
CLINICAL OUTCOME OF GLIOSARCOMA COMPARED WITH GLIOBLASTOMA-MULTIFORME- NORTH CENTRAL CANCER-TREATMENT GROUP RESULTS
Authors: GALANIS E BUCKNER JC DINAPOLI RP SCHEITHAUER BW JENKINS RB WANG CH OFALLON JR FARR G
Citation: E. Galanis et al., CLINICAL OUTCOME OF GLIOSARCOMA COMPARED WITH GLIOBLASTOMA-MULTIFORME- NORTH CENTRAL CANCER-TREATMENT GROUP RESULTS, Journal of neurosurgery, 89(3), 1998, pp. 425-430
NEUROIMAGING AND TREATMENT IMPLICATIONS OF PATIENTS WITH MULTIPLE EPIDURAL SPINAL METASTASES
Authors: SCHIFF D ONEILL BP WANG CH OFALLON JR
Citation: D. Schiff et al., NEUROIMAGING AND TREATMENT IMPLICATIONS OF PATIENTS WITH MULTIPLE EPIDURAL SPINAL METASTASES, Cancer, 83(8), 1998, pp. 1593-1601
PROGRAMMATIC AND PRAGMATIC APPROACHES FOR QUALITY-OF-LIFE MEASUREMENT
Authors: SLOAN JA OFALLON JR SUMAN VJ SARGENT DJ
Citation: Ja. Sloan et al., PROGRAMMATIC AND PRAGMATIC APPROACHES FOR QUALITY-OF-LIFE MEASUREMENT, Quality of life research, 6(7-8), 1997, pp. 361-361
RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA
Authors: ELLIOTT TE DINAPOLI RP OFALLON JR KROOK JE EARLE JD MORTON RF LEVITT R TSCHETTER LK SCHEITHAUER BW PFEIFLE DM TWITO DI NELIMARK RA
Citation: Te. Elliott et al., RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA, Journal of neuro-oncology, 33(3), 1997, pp. 239-250
SUPRATENTORIAL GLIOMAS - A COMPARATIVE-STUDY BY GRADE AND HISTOLOGIC TYPE
Authors: SHAW EG SCHEITHAUER BW OFALLON JR
Citation: Eg. Shaw et al., SUPRATENTORIAL GLIOMAS - A COMPARATIVE-STUDY BY GRADE AND HISTOLOGIC TYPE, Journal of neuro-oncology, 31(3), 1997, pp. 273-278
AN EVALUATION OF POSTOPERATIVE FOLLOW-UP TESTS IN COLON-CANCER PATIENTS TREATED FOR CURE
Authors: PEETHAMBARAM P WEISS M LOPRINZI CL NOVOTNY P OFALLON JR ERLICHMAN C OCONNELL MJ LAURIE JA
Citation: P. Peethambaram et al., AN EVALUATION OF POSTOPERATIVE FOLLOW-UP TESTS IN COLON-CANCER PATIENTS TREATED FOR CURE, Oncology, 54(4), 1997, pp. 287-292
ASTROCYTOMA AND KI-67 - RESPONSE
Authors: CUNNINGHAM JM KIMMEL DW SCHEITHAUER BW OFALLON JR NOVOTNY PJ JENKINS RB
Citation: Jm. Cunningham et al., ASTROCYTOMA AND KI-67 - RESPONSE, Journal of neurosurgery, 87(1), 1997, pp. 133-134
ANALYSIS OF PROLIFERATION MARKERS AND P53 EXPRESSION IN GLIOMAS OF ASTROCYTIC ORIGIN - RELATIONSHIPS AND PROGNOSTIC VALUE
Authors: CUNNINGHAM JM KIMMEL DW SCHEITHAUER BW OFALLON JR NOVOTNY PJ JENKINS RB
Citation: Jm. Cunningham et al., ANALYSIS OF PROLIFERATION MARKERS AND P53 EXPRESSION IN GLIOMAS OF ASTROCYTIC ORIGIN - RELATIONSHIPS AND PROGNOSTIC VALUE, Journal of neurosurgery, 86(1), 1997, pp. 121-130
TOXICITY EVALUATION OF DIFLUOROMETHYLORNITHINE - DOSES FOR CHEMOPREVENTION TRIALS
Authors: LOPRINZI CL MESSING EM OFALLON JR POON MA LOVE RR QUELLA SK TRUMP DL MORTON RF NOVOTNY P
Citation: Cl. Loprinzi et al., TOXICITY EVALUATION OF DIFLUOROMETHYLORNITHINE - DOSES FOR CHEMOPREVENTION TRIALS, Cancer epidemiology, biomarkers & prevention, 5(5), 1996, pp. 371-374
TRANSDERMAL FENTANYL IN THE MANAGEMENT OF CANCER PAIN IN AMBULATORY PATIENTS - AN OPEN-LABEL PILOT-STUDY
Authors: HAMMACK JE MAILLIARD JA LOPRINZI CL ROSPOND RM OFALLON JR WILWERDING MB REUTER NF MICHALAK JC FIDLER P MISER AW
Citation: Je. Hammack et al., TRANSDERMAL FENTANYL IN THE MANAGEMENT OF CANCER PAIN IN AMBULATORY PATIENTS - AN OPEN-LABEL PILOT-STUDY, Journal of pain and symptom management, 12(4), 1996, pp. 234-240
PHASE-III DOUBLE-BLIND EVALUATION OF AN ALOE VERA GEL AS A PROPHYLACTIC AGENT FOR RADIATION-INDUCED SKIN TOXICITY
Authors: WILLIAMS MS BURK M LOPRINZI CL HILL M SCHOMBERG PJ NEARHOOD K OFALLON JR LAURIE JA SHANAHAN TG MOORE RL URIAS RE KUSKE RR ENGEL RE EGGLESTON WD
Citation: Ms. Williams et al., PHASE-III DOUBLE-BLIND EVALUATION OF AN ALOE VERA GEL AS A PROPHYLACTIC AGENT FOR RADIATION-INDUCED SKIN TOXICITY, International journal of radiation oncology, biology, physics, 36(2), 1996, pp. 345-349
OLSALAZINE IS CONTRAINDICATED DURING PELVIC RADIATION-THERAPY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL
Authors: MARTENSON JA HYLAND G MOERTEL CG MAILLIARD JA OFALLON JR COLLINS RT MORTON RF TEWFIK HH MOORE RL FRANK AR URIAS RE DEMING RL
Citation: Ja. Martenson et al., OLSALAZINE IS CONTRAINDICATED DURING PELVIC RADIATION-THERAPY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL, International journal of radiation oncology, biology, physics, 35(2), 1996, pp. 299-303
PRIMARY CENTRAL-NERVOUS-SYSTEM NON-HODGKINS-LYMPHOMA - SURVIVAL ADVANTAGES WITH COMBINED INITIAL THERAPY (VOL 33, PG 663, 1995)
Authors: ONEILL BP OFALLON JR EARLE JD COLGAN JP BROWN LD KRIGEL RL
Citation: Bp. Oneill et al., PRIMARY CENTRAL-NERVOUS-SYSTEM NON-HODGKINS-LYMPHOMA - SURVIVAL ADVANTAGES WITH COMBINED INITIAL THERAPY (VOL 33, PG 663, 1995), International journal of radiation oncology, biology, physics, 35(1), 1996, pp. 203-203
PHASE-II STUDY OF 5-FLUOROURACIL AND LEUCOVORIN IN RECURRENT PRIMARY BRAIN-TUMOR
Authors: CASCINO TL VEEDER MH BUCKNER JC OFALLON JR WIESENFELD M LEVITT R GOLDBERG RM KUROSS SA MORTON RF SCHEITHAUER BW
Citation: Tl. Cascino et al., PHASE-II STUDY OF 5-FLUOROURACIL AND LEUCOVORIN IN RECURRENT PRIMARY BRAIN-TUMOR, Journal of neuro-oncology, 30(3), 1996, pp. 243-246
RANDOMIZED TRIAL OF DIETITIAN COUNSELING TO TRY TO PREVENT WEIGHT-GAIN ASSOCIATED WITH BREAST-CANCER ADJUVANT CHEMOTHERAPY
Authors: LOPRINZI CL ATHMANN LM KARDINAL CG OFALLON JR SEE JA BRUCE BK DOSE AM MISER AW KERN PS TSCHETTER LK RAYSON S
Citation: Cl. Loprinzi et al., RANDOMIZED TRIAL OF DIETITIAN COUNSELING TO TRY TO PREVENT WEIGHT-GAIN ASSOCIATED WITH BREAST-CANCER ADJUVANT CHEMOTHERAPY, Oncology, 53(3), 1996, pp. 228-232
PROSPECTIVE EVALUATION OF A CHAMOMILE MOUTHWASH FOR PREVENTION OF 5-FU-INDUCED ORAL MUCOSITIS
Authors: FIDLER P LOPRINZI CL OFALLON JR LEITCH JM LEE JK HAYES DL NOVOTNY P CLEMENSSCHUTJER D BARTEL J MICHALAK JC
Citation: P. Fidler et al., PROSPECTIVE EVALUATION OF A CHAMOMILE MOUTHWASH FOR PREVENTION OF 5-FU-INDUCED ORAL MUCOSITIS, Cancer, 77(3), 1996, pp. 522-525
INSIGHTS FROM MONITORING THE CPCRA DIDANOSINE ZALCITABINE TRIAL
Authors: FLEMING TR NEATON JD GOLDMAN A DEMETS DL LAUNER C KORVICK J ABRAMS D BEERS D LOVELESS K MARTINEZ N MESARD CA REVES RR ROUFF JA KLEIN T MCDONALD R SLOTTEN R BROSGART C DREW L FESSEL J HUDSON R LOPEZ C THOMPSON S KUMI JO MASTROPOLAK D SARAVOLATZ LD KERKERING TM HIGGINSON RA GERNON L BAR M MENDEZ D ERNST J SCOTT J FINLEY B WARD D WISNIEWSKI T BRANDON W WALTER J CALHOUN C EBRIGHT JR SCHUMAN P BINCSIK A SWANSON K WINSLOW D SHERIDAN A TAYLOR V PEREZ G ELSADR W GUITY C JULEAU J SALVATI S DOWLING C SALVADOR GI BURNS AJ LAM SH CHILDRESS JF DEETS DL FLEMING TR MEYER KH POLLARD RB OFALLON JR RAHAL JJ WALTERS L WHITNEYWILLIAMS P WHITLEY RJ
Citation: Tr. Fleming et al., INSIGHTS FROM MONITORING THE CPCRA DIDANOSINE ZALCITABINE TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 9-18
A RANDOMIZED, CROSSOVER EVALUATION OF METHYLPHENIDATE IN CANCER-PATIENTS RECEIVING STRONG NARCOTICS
Authors: WILWERDING MB LOPRINZI CL MAILLIARD JA OFALLON JR MISER AW VANHAELST C BARTON DL FOLEY JF ATHMANN LM
Citation: Mb. Wilwerding et al., A RANDOMIZED, CROSSOVER EVALUATION OF METHYLPHENIDATE IN CANCER-PATIENTS RECEIVING STRONG NARCOTICS, Supportive care in cancer, 3(2), 1995, pp. 135-138
PENTOXIFYLLINE FOR TREATMENT OF CANCER ANOREXIA AND CACHEXIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: GOLDBERG RM LOPRINZI CL MAILLIARD JA OFALLON JR KROOK JE GHOSH C HESTORFF RD CHONG SF REUTER NF SHANAHAN TG
Citation: Rm. Goldberg et al., PENTOXIFYLLINE FOR TREATMENT OF CANCER ANOREXIA AND CACHEXIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Journal of clinical oncology, 13(11), 1995, pp. 2856-2859
PRIMARY CENTRAL-NERVOUS-SYSTEM NON-HODGKINS-LYMPHOMA - SURVIVAL ADVANTAGES WITH COMBINED INITIAL THERAPY
Authors: ONEILL BP OFALLON JR EARLE JD COLGAN JP BROWN LD KRIGEL RL
Citation: Bp. Oneill et al., PRIMARY CENTRAL-NERVOUS-SYSTEM NON-HODGKINS-LYMPHOMA - SURVIVAL ADVANTAGES WITH COMBINED INITIAL THERAPY, International journal of radiation oncology, biology, physics, 33(3), 1995, pp. 663-673
PHASE-II STUDY OF AMONAFIDE IN PATIENTS WITH RECURRENT GLIOMA
Authors: LEVITT R BUCKNER JC CASCINO TL BURCH PA MORTON RF WESTBERG MW GOLDBERG RM GALLAGHER JG OFALLON JR SCHEITHAUER BW
Citation: R. Levitt et al., PHASE-II STUDY OF AMONAFIDE IN PATIENTS WITH RECURRENT GLIOMA, Journal of neuro-oncology, 23(1), 1995, pp. 87-93
Risultati: 1-25 | 26-48